FVPI — FV Pharma International Income Statement
0.000.00%
Last trade - 00:00Consumer DefensivesAdventurousMicro Cap
Annual income statement for FV Pharma International, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2013 January 31st | 2014 January 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 0.002 | 0 |
| Cost of Revenue | ||
| Gross Profit | 0.002 | — |
| Selling / General / Administrative Expenses | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 0.001 | 0.031 |
| Operating Profit | 0.002 | -0.031 |
| Net Income Before Taxes | 0.002 | -0.031 |
| Provision for Income Taxes | ||
| Net Income After Taxes | 0.001 | -0.03 |
| Net Income Before Extraordinary Items | ||
| Net Income | 0.001 | -0.03 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Dilution Adjustment | ||
| Diluted Net Income | 0.001 | -0.03 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | 0.022 | -0.242 |
| Dividends per Share |